Cargando…
Streamlined human antibody generation and optimization by exploiting designed immunoglobulin loci in a B cell line
Monoclonal antibodies (mAbs) are widely utilized as therapeutic drugs for various diseases, such as cancer, autoimmune diseases, and infectious diseases. Using the avian-derived B cell line DT40, we previously developed an antibody display technology, namely, the ADLib system, which rapidly generate...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166883/ https://www.ncbi.nlm.nih.gov/pubmed/32457406 http://dx.doi.org/10.1038/s41423-020-0440-9 |
_version_ | 1783701588793098240 |
---|---|
author | Seo, Hidetaka Masuda, Hitomi Asagoshi, Kenjiro Uchiki, Tomoaki Kawata, Shigehisa Sasaki, Goh Yabuki, Takashi Miyai, Shunsuke Takahashi, Naoki Hashimoto, Shu-ichi Sawada, Atsushi Takaiwa, Aki Koyama, Chika Tamai, Kanako Kurosawa, Kohei Lin, Ke-Yi Ohta, Kunihiro Nakazaki, Yukoh |
author_facet | Seo, Hidetaka Masuda, Hitomi Asagoshi, Kenjiro Uchiki, Tomoaki Kawata, Shigehisa Sasaki, Goh Yabuki, Takashi Miyai, Shunsuke Takahashi, Naoki Hashimoto, Shu-ichi Sawada, Atsushi Takaiwa, Aki Koyama, Chika Tamai, Kanako Kurosawa, Kohei Lin, Ke-Yi Ohta, Kunihiro Nakazaki, Yukoh |
author_sort | Seo, Hidetaka |
collection | PubMed |
description | Monoclonal antibodies (mAbs) are widely utilized as therapeutic drugs for various diseases, such as cancer, autoimmune diseases, and infectious diseases. Using the avian-derived B cell line DT40, we previously developed an antibody display technology, namely, the ADLib system, which rapidly generates antigen-specific mAbs. Here, we report the development of a human version of the ADLib system and showcase the streamlined generation and optimization of functional human mAbs. Tailored libraries were first constructed by replacing endogenous immunoglobulin genes with designed human counterparts. From these libraries, clones producing full-length human IgGs against distinct antigens can be isolated, as exemplified by the selection of antagonistic mAbs. Taking advantage of avian biology, effective affinity maturation was achieved in a straightforward manner by seamless diversification of the parental clones into secondary libraries followed by single-cell sorting, quickly affording mAbs with improved affinities and functionalities. Collectively, we demonstrate that the human ADLib system could serve as an integrative platform with unique diversity for rapid de novo generation and optimization of therapeutic or diagnostic antibody leads. Furthermore, our results suggest that libraries can be constructed by introducing exogenous genes into DT40 cells, indicating that the ADLib system has the potential to be applied for the rapid and effective directed evolution and optimization of proteins in various fields beyond biomedicine. |
format | Online Article Text |
id | pubmed-8166883 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-81668832021-06-07 Streamlined human antibody generation and optimization by exploiting designed immunoglobulin loci in a B cell line Seo, Hidetaka Masuda, Hitomi Asagoshi, Kenjiro Uchiki, Tomoaki Kawata, Shigehisa Sasaki, Goh Yabuki, Takashi Miyai, Shunsuke Takahashi, Naoki Hashimoto, Shu-ichi Sawada, Atsushi Takaiwa, Aki Koyama, Chika Tamai, Kanako Kurosawa, Kohei Lin, Ke-Yi Ohta, Kunihiro Nakazaki, Yukoh Cell Mol Immunol Article Monoclonal antibodies (mAbs) are widely utilized as therapeutic drugs for various diseases, such as cancer, autoimmune diseases, and infectious diseases. Using the avian-derived B cell line DT40, we previously developed an antibody display technology, namely, the ADLib system, which rapidly generates antigen-specific mAbs. Here, we report the development of a human version of the ADLib system and showcase the streamlined generation and optimization of functional human mAbs. Tailored libraries were first constructed by replacing endogenous immunoglobulin genes with designed human counterparts. From these libraries, clones producing full-length human IgGs against distinct antigens can be isolated, as exemplified by the selection of antagonistic mAbs. Taking advantage of avian biology, effective affinity maturation was achieved in a straightforward manner by seamless diversification of the parental clones into secondary libraries followed by single-cell sorting, quickly affording mAbs with improved affinities and functionalities. Collectively, we demonstrate that the human ADLib system could serve as an integrative platform with unique diversity for rapid de novo generation and optimization of therapeutic or diagnostic antibody leads. Furthermore, our results suggest that libraries can be constructed by introducing exogenous genes into DT40 cells, indicating that the ADLib system has the potential to be applied for the rapid and effective directed evolution and optimization of proteins in various fields beyond biomedicine. Nature Publishing Group UK 2020-05-26 2021-06 /pmc/articles/PMC8166883/ /pubmed/32457406 http://dx.doi.org/10.1038/s41423-020-0440-9 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Seo, Hidetaka Masuda, Hitomi Asagoshi, Kenjiro Uchiki, Tomoaki Kawata, Shigehisa Sasaki, Goh Yabuki, Takashi Miyai, Shunsuke Takahashi, Naoki Hashimoto, Shu-ichi Sawada, Atsushi Takaiwa, Aki Koyama, Chika Tamai, Kanako Kurosawa, Kohei Lin, Ke-Yi Ohta, Kunihiro Nakazaki, Yukoh Streamlined human antibody generation and optimization by exploiting designed immunoglobulin loci in a B cell line |
title | Streamlined human antibody generation and optimization by exploiting designed immunoglobulin loci in a B cell line |
title_full | Streamlined human antibody generation and optimization by exploiting designed immunoglobulin loci in a B cell line |
title_fullStr | Streamlined human antibody generation and optimization by exploiting designed immunoglobulin loci in a B cell line |
title_full_unstemmed | Streamlined human antibody generation and optimization by exploiting designed immunoglobulin loci in a B cell line |
title_short | Streamlined human antibody generation and optimization by exploiting designed immunoglobulin loci in a B cell line |
title_sort | streamlined human antibody generation and optimization by exploiting designed immunoglobulin loci in a b cell line |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166883/ https://www.ncbi.nlm.nih.gov/pubmed/32457406 http://dx.doi.org/10.1038/s41423-020-0440-9 |
work_keys_str_mv | AT seohidetaka streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline AT masudahitomi streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline AT asagoshikenjiro streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline AT uchikitomoaki streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline AT kawatashigehisa streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline AT sasakigoh streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline AT yabukitakashi streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline AT miyaishunsuke streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline AT takahashinaoki streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline AT hashimotoshuichi streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline AT sawadaatsushi streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline AT takaiwaaki streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline AT koyamachika streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline AT tamaikanako streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline AT kurosawakohei streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline AT linkeyi streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline AT ohtakunihiro streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline AT nakazakiyukoh streamlinedhumanantibodygenerationandoptimizationbyexploitingdesignedimmunoglobulinlociinabcellline |